Industry: Medical Devices & Consumables
Published Date: 2026-04-17
Pages: 136 Pages
Report ld: 6474336
Request Sample
Customized Report
The global 3-in-1 Oral CBCT market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on 3-in-1 Oral CBCT competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Three-in-one oral CBCT refers to the addition of mid-field or small-field CBCT on the basis of a digital panoramic machine, which is a type of CBCT. The core global oral CBCT companies are KaVo Group, Planmeca, Dentsply Sirona, NewTom, Carestream, Vatech and Meyer, among which the share of the top five companies in the Chinese market has reached 60%.
This report delivers a comprehensive overview of the global 3-in-1 Oral CBCT market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding 3-in-1 Oral CBCT. The 3-in-1 Oral CBCT market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global 3-in-1 Oral CBCT market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist 3-in-1 Oral CBCT manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for 3-in-1 Oral CBCT manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines 3-in-1 Oral CBCT sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 3-in-1 Oral CBCT Market Overview
1.1 Product Definition
1.2 3-in-1 Oral CBCT by Type
1.2.1 Global 3-in-1 Oral CBCT Market Value by Type: 2025 vs 2032
1.2.2 Big FOV
1.2.3 Medium and Small FOV
1.3 3-in-1 Oral CBCT by Application
1.3.1 Global 3-in-1 Oral CBCT Market Value by Application: 2025 vs 2032
1.3.2 Private Clinic
1.3.3 Hospital
1.4 Global 3-in-1 Oral CBCT Market Size Estimates and Forecasts
1.4.1 Global 3-in-1 Oral CBCT Revenue 2021–2032
1.4.2 Global 3-in-1 Oral CBCT Sales 2021–2032
1.4.3 Global 3-in-1 Oral CBCT Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 3-in-1 Oral CBCT Market Competition by Manufacturers
2.1 Global 3-in-1 Oral CBCT Sales Market Share by Manufacturers (2021–2026)
2.2 Global 3-in-1 Oral CBCT Revenue Market Share by Manufacturers (2021–2026)
2.3 Global 3-in-1 Oral CBCT Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of 3-in-1 Oral CBCT, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of 3-in-1 Oral CBCT, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of 3-in-1 Oral CBCT, Product Types and Applications
2.7 Global Key Manufacturers of 3-in-1 Oral CBCT, Date of Entry into the Industry
2.8 Global 3-in-1 Oral CBCT Market Competitive Situation and Trends
2.8.1 Global 3-in-1 Oral CBCT Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global 3-in-1 Oral CBCT Players Market Share by Revenue
2.8.3 Global 3-in-1 Oral CBCT Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global 3-in-1 Oral CBCT Market Scenario by Region
3.1 Global 3-in-1 Oral CBCT Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global 3-in-1 Oral CBCT Sales by Region: 2021–2032
3.2.1 Global 3-in-1 Oral CBCT Sales by Region: 2021–2026
3.2.2 Global 3-in-1 Oral CBCT Sales by Region: 2027–2032
3.3 Global 3-in-1 Oral CBCT Revenue by Region: 2021–2032
3.3.1 Global 3-in-1 Oral CBCT Revenue by Region: 2021–2026
3.3.2 Global 3-in-1 Oral CBCT Revenue by Region: 2027–2032
3.4 North America 3-in-1 Oral CBCT Market Facts & Figures by Country
3.4.1 North America 3-in-1 Oral CBCT Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America 3-in-1 Oral CBCT Sales by Country (2021–2032)
3.4.3 North America 3-in-1 Oral CBCT Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe 3-in-1 Oral CBCT Market Facts & Figures by Country
3.5.1 Europe 3-in-1 Oral CBCT Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe 3-in-1 Oral CBCT Sales by Country (2021–2032)
3.5.3 Europe 3-in-1 Oral CBCT Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific 3-in-1 Oral CBCT Market Facts & Figures by Region
3.6.1 Asia Pacific 3-in-1 Oral CBCT Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific 3-in-1 Oral CBCT Sales by Region (2021–2032)
3.6.3 Asia Pacific 3-in-1 Oral CBCT Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America 3-in-1 Oral CBCT Market Facts & Figures by Country
3.7.1 Latin America 3-in-1 Oral CBCT Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America 3-in-1 Oral CBCT Sales by Country (2021–2032)
3.7.3 Latin America 3-in-1 Oral CBCT Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa 3-in-1 Oral CBCT Market Facts & Figures by Country
3.8.1 Middle East and Africa 3-in-1 Oral CBCT Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa 3-in-1 Oral CBCT Sales by Country (2021–2032)
3.8.3 Middle East and Africa 3-in-1 Oral CBCT Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global 3-in-1 Oral CBCT Sales by Type (2021–2032)
4.1.1 Global 3-in-1 Oral CBCT Sales by Type (2021–2026)
4.1.2 Global 3-in-1 Oral CBCT Sales by Type (2027–2032)
4.1.3 Global 3-in-1 Oral CBCT Sales Market Share by Type (2021–2032)
4.2 Global 3-in-1 Oral CBCT Revenue by Type (2021–2032)
4.2.1 Global 3-in-1 Oral CBCT Revenue by Type (2021–2026)
4.2.2 Global 3-in-1 Oral CBCT Revenue by Type (2027–2032)
4.2.3 Global 3-in-1 Oral CBCT Revenue Market Share by Type (2021–2032)
4.3 Global 3-in-1 Oral CBCT Price by Type (2021–2032)
5 Segment by Application
5.1 Global 3-in-1 Oral CBCT Sales by Application (2021–2032)
5.1.1 Global 3-in-1 Oral CBCT Sales by Application (2021–2026)
5.1.2 Global 3-in-1 Oral CBCT Sales by Application (2027–2032)
5.1.3 Global 3-in-1 Oral CBCT Sales Market Share by Application (2021–2032)
5.2 Global 3-in-1 Oral CBCT Revenue by Application (2021–2032)
5.2.1 Global 3-in-1 Oral CBCT Revenue by Application (2021–2026)
5.2.2 Global 3-in-1 Oral CBCT Revenue by Application (2027–2032)
5.2.3 Global 3-in-1 Oral CBCT Revenue Market Share by Application (2021–2032)
5.3 Global 3-in-1 Oral CBCT Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Vatech
6.1.1 Vatech Company Information
6.1.2 Vatech Description and Business Overview
6.1.3 Vatech 3-in-1 Oral CBCT Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Vatech 3-in-1 Oral CBCT Product Portfolio
6.1.5 Vatech Recent Developments/Updates
6.2 Pointnix
6.2.1 Pointnix Company Information
6.2.2 Pointnix Description and Business Overview
6.2.3 Pointnix 3-in-1 Oral CBCT Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Pointnix 3-in-1 Oral CBCT Product Portfolio
6.2.5 Pointnix Recent Developments/Updates
6.3 Planmeca
6.3.1 Planmeca Company Information
6.3.2 Planmeca Description and Business Overview
6.3.3 Planmeca 3-in-1 Oral CBCT Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Planmeca 3-in-1 Oral CBCT Product Portfolio
6.3.5 Planmeca Recent Developments/Updates
6.4 Instrumentarium
6.4.1 Instrumentarium Company Information
6.4.2 Instrumentarium Description and Business Overview
6.4.3 Instrumentarium 3-in-1 Oral CBCT Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Instrumentarium 3-in-1 Oral CBCT Product Portfolio
6.4.5 Instrumentarium Recent Developments/Updates
6.5 Genoray
6.5.1 Genoray Company Information
6.5.2 Genoray Description and Business Overview
6.5.3 Genoray 3-in-1 Oral CBCT Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Genoray 3-in-1 Oral CBCT Product Portfolio
6.5.5 Genoray Recent Developments/Updates
6.6 DEXIS
6.6.1 DEXIS Company Information
6.6.2 DEXIS Description and Business Overview
6.6.3 DEXIS 3-in-1 Oral CBCT Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 DEXIS 3-in-1 Oral CBCT Product Portfolio
6.6.5 DEXIS Recent Developments/Updates
6.7 FUSSEN
6.7.1 FUSSEN Company Information
6.7.2 FUSSEN Description and Business Overview
6.7.3 FUSSEN 3-in-1 Oral CBCT Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 FUSSEN 3-in-1 Oral CBCT Product Portfolio
6.7.5 FUSSEN Recent Developments/Updates
6.8 Ray Co., Ltd
6.8.1 Ray Co., Ltd Company Information
6.8.2 Ray Co., Ltd Description and Business Overview
6.8.3 Ray Co., Ltd 3-in-1 Oral CBCT Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Ray Co., Ltd 3-in-1 Oral CBCT Product Portfolio
6.8.5 Ray Co., Ltd Recent Developments/Updates
6.9 NewTom
6.9.1 NewTom Company Information
6.9.2 NewTom Description and Business Overview
6.9.3 NewTom 3-in-1 Oral CBCT Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 NewTom 3-in-1 Oral CBCT Product Portfolio
6.9.5 NewTom Recent Developments/Updates
6.10 KaVo Dental
6.10.1 KaVo Dental Company Information
6.10.2 KaVo Dental Description and Business Overview
6.10.3 KaVo Dental 3-in-1 Oral CBCT Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 KaVo Dental 3-in-1 Oral CBCT Product Portfolio
6.10.5 KaVo Dental Recent Developments/Updates
6.11 Beijing Largev
6.11.1 Beijing Largev Company Information
6.11.2 Beijing Largev Description and Business Overview
6.11.3 Beijing Largev 3-in-1 Oral CBCT Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Beijing Largev 3-in-1 Oral CBCT Product Portfolio
6.11.5 Beijing Largev Recent Developments/Updates
6.12 Shanghai Bondent
6.12.1 Shanghai Bondent Company Information
6.12.2 Shanghai Bondent Description and Business Overview
6.12.3 Shanghai Bondent 3-in-1 Oral CBCT Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Shanghai Bondent 3-in-1 Oral CBCT Product Portfolio
6.12.5 Shanghai Bondent Recent Developments/Updates
6.13 Guangzhou Huaduantech
6.13.1 Guangzhou Huaduantech Company Information
6.13.2 Guangzhou Huaduantech Description and Business Overview
6.13.3 Guangzhou Huaduantech 3-in-1 Oral CBCT Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Guangzhou Huaduantech 3-in-1 Oral CBCT Product Portfolio
6.13.5 Guangzhou Huaduantech Recent Developments/Updates
6.14 Shenzhen Angell
6.14.1 Shenzhen Angell Company Information
6.14.2 Shenzhen Angell Description and Business Overview
6.14.3 Shenzhen Angell 3-in-1 Oral CBCT Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Shenzhen Angell 3-in-1 Oral CBCT Product Portfolio
6.14.5 Shenzhen Angell Recent Developments/Updates
6.15 Hefei Meyer
6.15.1 Hefei Meyer Company Information
6.15.2 Hefei Meyer Description and Business Overview
6.15.3 Hefei Meyer 3-in-1 Oral CBCT Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Hefei Meyer 3-in-1 Oral CBCT Product Portfolio
6.15.5 Hefei Meyer Recent Developments/Updates
6.16 Carestream Health
6.16.1 Carestream Health Company Information
6.16.2 Carestream Health Description and Business Overview
6.16.3 Carestream Health 3-in-1 Oral CBCT Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Carestream Health 3-in-1 Oral CBCT Product Portfolio
6.16.5 Carestream Health Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 3-in-1 Oral CBCT Industry Chain Analysis
7.2 3-in-1 Oral CBCT Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 3-in-1 Oral CBCT Production Mode & Process Analysis
7.4 3-in-1 Oral CBCT Sales and Marketing
7.4.1 3-in-1 Oral CBCT Sales Channels
7.4.2 3-in-1 Oral CBCT Distributors
7.5 3-in-1 Oral CBCT Customer Analysis
8 3-in-1 Oral CBCT Market Dynamics
8.1 3-in-1 Oral CBCT Industry Trends
8.2 3-in-1 Oral CBCT Market Drivers
8.3 3-in-1 Oral CBCT Market Challenges
8.4 3-in-1 Oral CBCT Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for 3-in-1 Oral CBCT was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 153
USD 3950.00
(Single User License)
The global 3-in-1 Oral CBCT market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 104
USD 4250.00
(Single User License)
The global 3-in-1 Oral CBCT market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 176
USD 4900.00
(Single User License)
The global market for 3-in-1 Oral CBCT was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 133
USD 3950.00
(Single User License)
The global market for 3-in-1 Oral CBCT was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 102
USD 2900.00
(Single User License)
The global 3-in-1 Oral CBCT market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-15
Pages: 113
USD 4900.00
(Single User License)
The global 3-in-1 Oral CBCT market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-18
Pages: 103
USD 2900.00
(Single User License)
The global market for 3-in-1 Oral CBCT was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 153
The global 3-in-1 Oral CBCT market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 104
The global 3-in-1 Oral CBCT market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 176
The global market for 3-in-1 Oral CBCT was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 133
The global market for 3-in-1 Oral CBCT was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 102
The global 3-in-1 Oral CBCT market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-15
Pages: 113
The global 3-in-1 Oral CBCT market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-18
Pages: 103
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now